BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 38786013)

  • 1. Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood-Brain Barrier.
    Cogill SA; Lee JH; Jeon MT; Kim DG; Chang Y
    Cells; 2024 May; 13(10):. PubMed ID: 38786013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.
    Li J; Zheng M; Shimoni O; Banks WA; Bush AI; Gamble JR; Shi B
    Adv Sci (Weinh); 2021 Aug; 8(16):e2101090. PubMed ID: 34085418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y; Liu L
    Adv Drug Deliv Rev; 2012 May; 64(7):640-65. PubMed ID: 22154620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations When Developing Blood-Brain Barrier Crossing Drug Delivery Technology.
    Bell RD
    Handb Exp Pharmacol; 2022; 273():83-95. PubMed ID: 34463850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG; Gaillard PJ
    Clin Pharmacokinet; 2007; 46(7):553-76. PubMed ID: 17596102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental methods and transport models for drug delivery across the blood-brain barrier.
    Fu BM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1346-59. PubMed ID: 22201587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategies for Brain Drug Delivery.
    Dong X
    Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS drug delivery systems: novel approaches.
    Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease.
    Agrawal M; Ajazuddin ; Tripathi DK; Saraf S; Saraf S; Antimisiaris SG; Mourtas S; Hammarlund-Udenaes M; Alexander A
    J Control Release; 2017 Aug; 260():61-77. PubMed ID: 28549949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving new-age strategies to transport therapeutics across the blood-brain-barrier.
    Choudhari M; Hejmady S; Narayan Saha R; Damle S; Singhvi G; Alexander A; Kesharwani P; Kumar Dubey S
    Int J Pharm; 2021 Apr; 599():120351. PubMed ID: 33545286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in delivery of biotherapeutics across the blood-brain barrier.
    Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
    Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
    Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
    Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vector-mediated drug delivery to the brain.
    Temsamani J; Rousselle C; Rees AR; Scherrmann JM
    Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.